Warning: session_start(): open(/home/tayedi/public_html/src/var/sessions/sess_1c9d8d345a0189e2516723e5d7bfaebe, O_RDWR) failed: No space left on device (28) in /home/tayedi/public_html/src/bootstrap.php on line 59

Warning: session_start(): Failed to read session data: files (path: /home/tayedi/public_html/src/var/sessions) in /home/tayedi/public_html/src/bootstrap.php on line 59
Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen. - Tayedi Search engine

Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.

2 hours ago 2

Novo Nordisk on Tuesday received a broker downgrade, with the analysts arguing that its status as a duopoly in both diabetes and weight loss are under threat.

Read Entire Article

Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.

Related

While markets react to global conflict, BI DeFi users are st...

Bill Ackman tries again with plan for IPO of Pershing Square...

US lawmakers probe Trump family-linked firm over Chinese sto...

Trending

Popular

More companies than usual are beating Wall Street’s expectat...

Binance teams up with Franklin Templeton to use tokenized mo...

Here are 7 charts guaranteed to stress you out about the sto...

Bitcoin remains in tight range under $70,000 ahead of Wednes...

LayerZero unveils ‘Zero’ chain, with Citadel, ARK backing

ETH open interest falls to 3-year low: What does it mean for...

Memory-chip stocks are still quite cheap — especially if you...

These ‘safer’ chip stocks have boomed this year. Is it too l...

Ledger adds OKX DEX integration for on-device token swaps

All social program benefits can be distributed onchain: Comp...